IFN-related genes are associated with genetic susceptibility to SLE, and elevated serum IFN levels enhance disease activity and increase the risk of relapse in SLE patients [137], thereby promoting the dysfunction of endothelial progenitor cells [138]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.